Can stage-IIB lung cancer be divided into subgroups in terms of prognosis? A modelling study^*

References

• Rami-Porta R. Towards the 9th edition of the tumour, node and metastasis classification of lung cancer. A historical appraisal and future perspectives. ATD. 2019. https://mbmj.org/index.php/atd/article/view/141.
   Google Scholar
• Asamura H, Chansky K, Crowley J, et al. The ınternational association for the study of lung cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(12):1675–1684. doi: 10.1097/JTO.0000000000000678.
   PubMed Web of Science ®Google Scholar
• Rami-Porta R, Asamura H, Travis WD, et al. Lung cancer-major changes in the American joint committee on cancer eight edition staging manual. CA Cancer J Clin. 2017;67(2):138–155. doi: 10.3322/caac.21390.
   PubMed Web of Science ®Google Scholar
• Shin JW, Cho DG, Choi SY, et al. Prognostic factors in stage IIB Non-Small cell lung cancer according to the 8th edition of TNM staging system. Korean J Thorac Cardiovasc Surg. 2019;52(3):131–140. doi: 10.5090/kjtcs.2019.52.3.131.
   PubMedGoogle Scholar
• Sayan M, Valiyev E, Bas A, et al. Outcomes of surgically treated patients with stage IIB non-small cell lung cancer, a single center experience. Indian J Surg. 2020;82(4):639–645. doi: 10.1007/s12262-020-02084-3.
   Web of Science ®Google Scholar
• Yin N, Ha M, Liu Y, et al. Prognostic significance of subclassification of stage IIB lung cancer: a retrospective study of 226 patients. Oncotarget. 2017;8(28):45777–45783. doi: 10.18632/oncotarget.17405.
   PubMedGoogle Scholar
• Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51. doi: 10.1016/j.jtho.2015.09.009.
   PubMed Web of Science ®Google Scholar
• Citak N, Buyukkale S, Kok A, et al. Does video-assisted mediastinoscopy offer lower false-negative rates for subcarinal lymph nodes compared with standard cervical mediastinoscopy? Thorac Cardiovasc Surg. 2014;62(7):624–630. doi: 10.1055/s-0033-1358656.
   PubMed Web of Science ®Google Scholar
• Çitak N, Guglielmetti L, Aksoy Y, et al. Is there a prognostic difference between stage IIIA subgroups in lung cancer? Ann Thorac Surg. 2021;112(5):1656–1663. doi: 10.1016/j.athoracsur.2020.10.033.
   PubMed Web of Science ®Google Scholar
• Griff S, Taber S, Bauer TT, et al. Prognostic significance of the pattern of pathological N1 lymph node metastases for non-small cell lung cancer. J Thorac Dis. 2019;11(8):3449–3458. doi: 10.21037/jtd.2019.07.73.
   PubMed Web of Science ®Google Scholar
• Eichhorn F, Klotz LV, Muley T, et al. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: a retrospective single-center analysis. Lung Cancer. 2019;138:95–101. doi: 10.1016/j.lungcan.2019.10.018.
   PubMed Web of Science ®Google Scholar
• Wang J, Wu N, Lv C, et al. External validation of the eighth edition of the TNM classification for lung cancer in 3,611 surgically treated patients at a single institution. Ann Transl Med. 2020;8(4):122–122. doi: 10.21037/atm.2020.01.128.
   PubMed Web of Science ®Google Scholar
• Liu CY, Hung JJ, Wang BY, et al. Prognostic factors in resected pathological N1-stage II non small cell lung cancer. Eur Respir J. 2013;41(3):649–655. doi: 10.1183/09031936.00058512.
   PubMed Web of Science ®Google Scholar
• Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eight edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(7):990–1003. doi: 10.1097/JTO.0000000000000559.
   PubMed Web of Science ®Google Scholar
• Aksoy Y, Çıtak N, Obuz Ç, et al. Does anatomical location-based metastatic lymph node density affect prognosis in lung cancer patients? Interact Cardiovasc Thorac Surg. 2021;33(4):541–549. doi: 10.1093/icvts/ivab119.
   PubMed Web of Science ®Google Scholar
• Citak N, Aksoy Y, Isgörücü Ö, et al. A comparison of the currently used nodal stage classification with the number of metastatic lymph nodes and the number of metastatic lymph node stations for non-small cell lung cancer; which of these ıs the best prognostic factor? Zentralbl Chir. 2020;145(6):565–573. doi: 10.1055/a-1008-9598.
   PubMedGoogle Scholar
• Pathak R, Goldberg SB, Canavan M, et al. Association of survival with adjuvant chemotherapy among patients with early-stage non–small cell lung cancer with vs without high-risk clinicopathologic features. JAMA Oncol. 2020;6(11):1741–1750. doi: 10.1001/jamaoncol.2020.4232.
   PubMed Web of Science ®Google Scholar
• Stokes SM, Massarweh NN, Stringham JR, et al. Impact of multimodality treatment sequence on survival in stage IIB non-small cell lung cancer. Ann Thorac Surg. 2021;112(5):1559–1567. doi: 10.1016/j.athoracsur.2020.12.008.
   PubMed Web of Science ®Google Scholar